Target Audience

The educational design of this activity addresses the needs of family practice physicians, nurse practitioners, and physician assistants, as well as internal medicine clinicians, obstetrics and gynecology clinicians, geriatricians, and other specialists related to early cancer detection.

Program Overview

This CME Jeopardy™ educational activity is designed to provide an engaging and informative learning session on blood-based multi-cancer early detection (MCED) screening in the primary care setting. The program will begin with a didactic presentation of key content related to gaps and limitations of current guideline-recommended cancer screening modalities, the science and data behind MCED tests, and practical information on the potential use of MCED screening in clinical practice.

Educational Objectives

After completing this activity, the participant should be better able to:

1. Describe the role of blood-based cancer screening in addressing the limitations of current guideline-recommended screening modalities and improving early cancer detection rates
2. Explain the use of methylated cell-free DNA for the early detection of various cancer types and their tissue of origin
3. Discuss recent clinical trial and real-world data on available and emerging blood-based MCED screening tests
4. Integrate MCED screening into primary care practice, including patient eligibility criteria, shared decision-making, and appropriate follow-up pathways

Physician Accreditation Statement

Integritas Communications is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Continuing Medical Education

Integritas designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions to Receive Credit

In order to receive credit for this activity, the participant must score at least 75% on the posttest and complete the program evaluation.

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.

Disclosures of Conflicts of Interest

Integritas adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Integritas are required to disclose all financial relationships with any ineligible company within the past 24 months to Integritas. All financial relationships reported are identified as relevant and mitigated by Integritas in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Integritas to assure objectivity and that the activity is free of commercial bias. 

All relevant financial relationships have been mitigated.

The faculty have the following relevant financial relationships with ineligible companies:

Mark D. Gomez, MD: Fees for Non-CE Services Received Directly from an Ineligible Entity or their Agents (eg, Speakers’ Bureaus): GRAIL, Inc.

Gautum Agarwal, MD, FACS: Consulting Fees: GRAIL, Inc., Natera; Tempus

Mylynda B. Massart, MD, PhD: Fees for Non-CE Services Received Directly from an Ineligible Entity or their Agents (eg, Speakers’ Bureaus): GRAIL, Inc.

The Integritas planners and managers have no relevant financial relationships with ineligible companies.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Integritas does not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.